Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents

  • Nickoloff B
  • Osborne B
  • Miele L
243Citations
Citations of this article
124Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Notch signaling controls cell fate decisions including during development and stem cell renewal and differentiation in many postnatal tissues. Increasing evidence suggests that the Notch signaling network is frequently deregulated in human malignancies and that genetic or pharmacological manipulation of Notch signaling is a novel potential strategy for the treatment of human neoplasms. This review article summarizes the most recent preclinical and clinical evidence linking Notch signaling to cancer, delineates questions that remain unanswered and explores potential biopharmacological strategies to manipulate Notch signaling in vivo.

Cite

CITATION STYLE

APA

Nickoloff, B. J., Osborne, B. A., & Miele, L. (2003). Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents. Oncogene, 22(42), 6598–6608. https://doi.org/10.1038/sj.onc.1206758

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free